Skip to main content
CREO MEDICAL GROUP PLC logo

CREO MEDICAL GROUP PLC — Investor Relations & Filings

Ticker · CREO ISIN · GB00BZ1BLL44 LEI · 213800H188ZDCWWXFA21 IL Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2024-10-21 Director's Dealing
Country GB United Kingdom
Listing IL CREO

About CREO MEDICAL GROUP PLC

https://www.creomedical.com/

Creo Medical Group PLC is a medical device company specializing in the development and commercialization of minimally invasive electrosurgical devices for therapeutic endoscopy. The company's core technology platform integrates advanced bipolar radiofrequency for precise tissue cutting with high-frequency microwave energy for controlled coagulation. Its principal products, such as the Speedboat device, are designed to enable clinicians to perform complex procedures like endoscopic submucosal dissection (SSD) to remove gastrointestinal lesions. By providing alternatives to traditional surgery, Creo Medical aims to improve patient outcomes, reduce recovery times, and lower healthcare costs. The company also provides extensive clinical education and training programs to support healthcare professionals in adopting its advanced energy technologies.

Recent filings

Filing Released Lang Actions
Director/PDMR Share Dealings
Director's Dealing Classification · 1% confidence The document is titled 'Director/PDMR Share Dealings' and contains detailed tables showing transactions (purchases) of Ordinary Shares by named directors (Kevin Crofton and Richard Rees). It explicitly uses the regulatory heading 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. This directly corresponds to the definition of Director's Dealing (DIRS). The presence of the RNS Number and the LSE context confirms it is a regulatory disclosure, but the specific content points precisely to DIRS.
2024-10-21 English
Result of General Meeting & TVR
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement released via RNS (RNS Number: 7921I) on October 18, 2024. The primary content announces the 'Result of General Meeting' where all resolutions were passed. It also provides an update on the 'Total Voting Rights' following a share issuance. This combination of announcing the outcome of a shareholder vote (General Meeting results) and providing a subsequent voting rights calculation strongly aligns with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it is an RNS filing, DVA is a more specific and accurate classification for the core subject matter than the general 'RNS' fallback.
2024-10-18 English
Result of Retail Offer
AGM Information Classification · 1% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content announces the 'Result of Retail Offer' and details the number of shares to be issued, the issue price, and the expected admission to trading on AIM. This is a specific corporate action announcement related to capital raising/share issuance, but the format and source (RNS) strongly suggest it is a general regulatory announcement. Since it details the outcome of a share issuance/placing, it relates to capital structure changes. However, given the context of RNS distribution and the nature of the announcement (a specific result following a prior offer), it fits best under the general regulatory announcement category (RNS) or potentially Capital/Financing Update (CAP). Since it is a formal announcement distributed via RNS regarding the finalization of a share issue, RNS is the most appropriate general classification for this type of regulatory news release, although CAP is also relevant. Given the strong RNS branding, I will classify it as RNS, which serves as the fallback for specific regulatory news releases not covered by other detailed codes like 10-K or ER.
2024-10-17 English
Extension of Retail Offer Closing Date
Share Issue/Capital Change Classification · 1% confidence The document is identified by the RNS Number header and the explicit mention that the information is provided by RNS, the news service of the London Stock Exchange. The content discusses an extension of a 'Retail Offer' and provides a revised timetable for a General Meeting and the closing of the offer, which relates to capital raising/share issuance activities. However, the primary function of this specific document is to announce a procedural update regarding an ongoing corporate action (the Retail Offer) and the associated General Meeting timetable. Since it is a formal regulatory announcement distributed via RNS, and it details changes to a fundraising timetable, it fits best under the general 'Regulatory Filings' category (RNS) as a broad announcement, or potentially 'Capital/Financing Update' (CAP) due to the subject matter. Given the structure (RNS header, short announcement format detailing an update rather than the full details of the financing itself), RNS is the most appropriate general classification for an RNS distribution notice. It is not a full report (10-K, IR), nor is it solely a dividend notice (DIV) or management change (MANG). It is a regulatory news service announcement.
2024-10-04 English
Result of Placing
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement (RNS Number : 4128G) from Creo Medical Group PLC, dated October 1, 2024. The content explicitly announces the 'Result of Placing' where the company raised approximately £12 million through the issue of new shares. This is a direct announcement regarding a financing activity (fundraising/placing). This fits the definition of 'Capital/Financing Update' (CAP). Although it is an RNS announcement, the core subject matter is the capital raise itself, not just the announcement of a report, making CAP more specific than the fallback RNS. The document also mentions that a Circular regarding the General Meeting is expected later today, which might suggest an RPA, but the primary focus is the successful completion and details of the Placing, which is a capital event.
2024-10-01 English
Retail Offer for up to £5.0 million
Regulatory Filings Classification · 1% confidence The document is an official announcement from Creo Medical Group PLC, identified by the RNS Number (3043G) and the use of the National Storage Mechanism header, indicating it is a regulatory filing disseminated via a Regulatory Information Service (RIS). The core content announces a 'Retail Offer for up to £5.0 million' through the issue of new ordinary shares. This activity—raising capital through the issuance of new shares to existing retail shareholders—falls directly under the definition of a capital/financing update. While it is a formal announcement, the specific nature of the transaction (share issuance for fundraising) makes 'Capital/Financing Update' (CAP) a more precise classification than the general 'Regulatory Filing' (RNS). It is not a full report (10-K, IR), a dividend notice (DIV), or a management change (MANG). Since it details the terms, price, and timetable for a capital raise, CAP is the best fit.
2024-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.